title: Insulin-dependent tyrosine phosphorylation of the vav protooncogene product in cells of hematopoietic origin.
abstract: Insulin activates the ras signaling pathway and promotes hematopoietic cell proliferation. One possible mediator in such signaling is the vav proto-oncogene product (p95vav), which is specifically expressed in cells of hematopoietic origin and contains domains typical of guanine nucleotide exchange factors as well as Src homology 2 and Src homology 3 domains. We studied the tyrosine phosphorylation of p95vav in hematopoietic cells expressing insulin receptors. Immunoblotting experiments with an antiphosphotyrosine monoclonal antibody disclosed that insulin induces rapid and transient tyrosine phosphorylation of p95vav in the human U-266 myeloma cell line. These findings were confirmed by immunoprecipitation experiments performed with 32P-labeled cells and phosphoamino acid analysis of the bands corresponding to p95vav. Similarly, insulin-dependent tyrosine phosphorylation of p95vav was observed in the human IM-9 and mouse J558L hematopoietic cell lines. Furthermore, insulin treatment of cells led to the association of the Src homology 2 domain of p95vav with the activated beta-subunit of the insulin receptor in vitro. Altogether, these data suggest that p95vav is a substrate for the insulin receptor tyrosine kinase and may be involved in an insulin signaling pathway linking receptor-generated signals to Ras or other GTP-binding proteins in cells of hematopoietic origin.
authors.affiliation: Division of Hematology-Oncology, Loyola University of Chicago, Maywood, Illinois 60153, USA.
authors.forename: S
authors.initials: S
authors.lastname: Uddin
authors.forename: S
authors.initials: S
authors.lastname: Katzav
authors.forename: M F
authors.initials: MF
authors.lastname: White
authors.forename: L C
authors.initials: LC
authors.lastname: Platanias
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D018797:Cell Cycle Proteins; D002460:Cell Line; D005982:Glutathione Transferase / Q000096:biosynthesis; D006801:Humans; D007328:Insulin / Q000494:pharmacology*; D009101:Multiple Myeloma; D010710:Phosphates / Q000378:metabolism; D010761:Phosphorus Radioisotopes; D010766:Phosphorylation; D019000:Phosphotyrosine; D011494:Protein Kinases / Q000378:metabolism; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis / Q000302:isolation & purification / Q000378:metabolism*; D051567:Proto-Oncogene Proteins c-vav; D011519:Proto-Oncogenes; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000378:metabolism; D014407:Tumor Cells, Cultured; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000032:analysis / Q000378:metabolism
chemical_list: D018797:Cell Cycle Proteins; D007328:Insulin; C000715470:MAS1 protein, human; D010710:Phosphates; D010761:Phosphorus Radioisotopes; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins; D051567:Proto-Oncogene Proteins c-vav; D011993:Recombinant Fusion Proteins; C496618:VAV1 protein, human; D019000:Phosphotyrosine; D014443:Tyrosine; D000255:Adenosine Triphosphate; D005982:Glutathione Transferase; D011494:Protein Kinases